Dr Ron Riegelhaupt & Assoc is categorized under Podiatrists in Glenview, IL and active since 1986.
Dr Ron Riegelhaupt & Assoc was established in 1986, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Podiatrists business, which does work in the B2C market, and is classified as a Podiatrists, under code number 6213910 by the NAICS.
If you are seeking more information, feel free to contact Ron Riegelhaupt, Owner at the company’s single location by writing to 1775 Glenview Road # 115, Glenview, Illinois IL 60025 or by phoning (847) 729-4710. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Dr Ron Riegelhaupt & Assoc |
| Contact Person: | Ron Riegelhaupt, Owner |
| Address: | 1775 Glenview Road # 115, Glenview, Illinois 60025 |
| Phone Number: | (847) 729-4710 |
| Website Address: | rfootdoctor.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1986 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Podiatrists |
| SIC Code: | 8043 |
| NAICS Code: | 6213910 |
| Share This Business: |
Dr Ron Riegelhaupt & Assoc was started in 1986 to provide professional Podiatrists under the SIC code 8043 and NAICS code 6213910. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Ron Riegelhaupt, Owner for inquiries that concern Dr Ron Riegelhaupt & Assoc by calling the company number (847) 729-4710, as your correspondence is most welcome. Additionally, the physical location of the single location of Dr Ron Riegelhaupt & Assoc can be found at the coordinates 42.07268,-87.80194 as well as the street address 1775 Glenview Road # 115 in Glenview, Illinois 60025.
For its online presence, you may visit Dr Ron Riegelhaupt & Assoc’s website at rfootdoctor.com and engage with its social media outlets through on Twitter and on Facebook.